De - und Remyelinisierung in Dopaminrezeptor-defizienten Mäusen

Schultz, Katharina

dc.contributor.advisor	Stadelmann-Nessler, Christine Prof. Dr.	de
dc.contributor.author	Schultz, Katharina	de
dc.date.accessioned	2013-01-14T15:19:05Z	de
dc.date.available	2013-01-30T23:51:27Z	de
dc.date.issued	2012-05-31	de
dc.identifier.uri	http://hdl.handle.net/11858/00-1735-0000-000D-EFBE-6	de
dc.identifier.uri	http://dx.doi.org/10.53846/goediss-1535
dc.format.mimetype	application/pdf	de
dc.language.iso	ger	de
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/	de
dc.title	De - und Remyelinisierung in Dopaminrezeptor-defizienten Mäusen	de
dc.type	doctoralThesis	de
dc.title.translated	De-and remyelination in dopamine receptor-deficient mice	de
dc.contributor.referee	Stadelmann-Nessler, Christine Prof. Dr.	de
dc.date.examination	2012-06-27	de
dc.subject.dnb	610 Medizin, Gesundheit	de
dc.subject.gok	MED 531	de
dc.description.abstracteng	De-and remyelination in dopamine receptor-deficient mice Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous-system with destruction of myelin sheaths, axonal damage and only partial remyelination. In non remyelinated MS lesions there is often a significant loss of oligodendrocytes. The destruction of oligodendrocytes happens predominantly at the beginning a lesion occurs. In this work the effect of the dopamine D2 receptor (DRD2) and D3 (DRD3) and dopamine agonist pramipexole relating to the oligodendroglial survival in the model of cuprizone-induced demyelination has been tested for toxicity. The literature has shown the expression of DRD2 and DRD3 on oligodendrocyte percusor cells (OPCs) and an effect on the extent of concentration of oligodendrocytes. Our hypothesis is that dopamine receptor-deficient mice compared to wild type (wt) mice have shown an increased vulnerability of oligodendrocytes. Furthermore, it should be investigated how far the therapy with pramipexole, a dopamine D3 receptor agonist, receptor-independent or dependent, leads to a protection of oligodendrocytes. With the help of various histological and immunohistochemical methods we were allowed to count the density of apoptotic oligodendrocytes and activated microglia, which drew conclusions from the extent of tissue damage. We could not find significant differences in the density of apoptotic oligodendrocytes and activated microglia between the different experimental groups. In one experiment, more apoptotic oligodendrocytes were found in the animals of the wild-type PBS (phosphate buffered saline) group compared with the pramipexole-treated DRD3 knockout mice, which may allow to draw conclusions from receptor-independent effects of pramipexole. These results must be reproduced in further studies in detail and will have to be verified. So it appears that endogenous dopamine receptor system plays no significant role in our results - the protection of oligodendrocytes in cuprizone-induced damage. Furthermore, a preventive-protective effect of pramipexole can	de
dc.contributor.coReferee	Simons, Mikael Prof. Dr.	de
dc.contributor.thirdReferee	Liebetanz, David Prof. Dr.	de
dc.subject.topic	Medicine	de
dc.subject.ger	Multiple Sklerose - Neuropathologie - Dopaminrezeptordefizienz - Pramipexol - Oligodendrocytenvorläuferzellen OPCs	de
dc.subject.eng	muliple sclerosis - neuropathology - dopamine receptor deficiency - pramipexole - oligodendrocyte percusor cells OPCs	de
dc.subject.bk	44.90	de
dc.identifier.urn	urn:nbn:de:gbv:7-webdoc-3533-0	de
dc.identifier.purl	webdoc-3533	de
dc.affiliation.institute	Medizinische Fakultät	de
dc.identifier.ppn	726808385	de

Files in this item

Name:schultz.pdf

Size:964.8Kb

Format:PDF

View/Open

Name:: schultz.pdf
Size:: 964.8Kb
Format:: PDF

View/Open

This item appears in the following Collection(s)

Human- und Zahnmedizin [3013]

Show simple item record